Indapta Therapeutics Announces Data Demonstrating G-NK Cells Enhance Efficacy in Multiple Myeloma
Indapta Therapeutics, Inc. today announced the publication of new preclinical data in Blood Advances demonstrating the company’s proprietary…
PharmaCyte Biotech Announces Uplist to Nasdaq Capital Market and Public Offering
Biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCBD), a company concentrated on creating cellular therapies for cancer cells and…
Recent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data
A recent report published by the American Association for Cancer Research titled Subgroup Analyses in Oncology Trials: Regulatory…
Rapid Dose Therapeutics Announces Formation & Appointment of Advisory Board
Rapid Dose Therapeutics (CSE:DOSE) is a biotechnology company revolutionizing drug delivery through innovation, specifically with their flagship product…
Stevanato Announces Proposed Initial Public Offering (IPO)
Stevanato, the Italian family-owned yet global manufacturer and provider of drug containment, drug delivery and diagnostic solutions, has…
William Blair Biotech Focus Conference 2021 Panel Schedule
Day One 2021 William Blair Biotech Conference July 14th Panels Panel Name: Cell Therapies in the Next Decade…
BioLab Sciences Appoints New VP of Sales Mark Denning
Emerging regenerative biotechnology company BioLab Sciences announced today that it has appointed industry veteran Mark Denning as VP…
Allay Therapeutics Appoints New Chief Medical Officer
David Hewitt, M.D. Appointed as New Allay Therapeutics Chief Medical Officer Clinical-stage biotechnology company Allay Therapeutics recently announced…
Presenters Announced for 2021 William Blair Biotech Conference
A wide range of biotechnology companies have announced presentations at the upcoming William Blair Biotech Conference slated to…
Cel-Sci Announces Multikine Immunotherapy Significantly Improves Overall Survival Benefit for Cancer Head & Neck Patients in Phase 3 Trial
Data Shows Significant Overall Survival Benefit for Cancer Patients with Multikine Treatment Regimen Followed by Surgery & Radiotherapy…
Moderna Announces Ministry of Food and Drug Safety of South Korea (MFDS) COVID-19 Authorization
Moderna, Inc., (NASDAQ: MRNA) has recently been authorized by the Ministry of Food and Drug Safety of South…
COVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive – Virology Experts Weigh In
Professional Major League Baseball organization the New York Yankees have been rocked this week with COVID-19 after 8…
Capricor CEO to Present at American Society of Gene and Cell Therapy Annual Meeting Ahead of Q1 Earnings Update
May 13 is a busy day for biotechnology company Capricor Therapeutics (NASDAQ: CAPR). The company which focuses on…
NTx Hires Bristol-Myers Squibb Veteran Biopharma Executive Nancy Rurkowski to Join its Board of Directors
The 35-year veteran of Bristol-Myers Squibb brings manufacturing operations and product launch leadership expertise to drive NTx commercialization…
Aerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital
Aerobiotix, a pioneer in airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long…
Maxwell Biosciences, Makers of CLAROMER, Hire John Lord, Ph.D., as VP of Research and Development
Austin, Texas based biotechnology company Maxwell Biosciences have announced the hiring of Dr. John Lord as Vice President…
Ex-Lilly CEO Josh Bilenker & Ex-Novartis Head of Oncology Jeff Engelman Announce Treeline Biosciences
Two powerhouse executives have joined forces to form a brand new cancer Biotech company. Josh Bilenker, M.D., and…
Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors
The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with…